Skip to content

Artificial Intelligence-Based Gait-Aware Closed-Loop Neuromodulation: Application of rTMS and Lower-Limb Flexible Exoskeleton Robot in Stroke Gait and Walking Function

Artificial Intelligence-Based Gait-Aware Closed-Loop Neuromodulation: Application of rTMS and Lower-Limb Flexible Exoskeleton Robot in Stroke Gait and Walking Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123543
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:conventional walking training
Exo group:Wearable Lower-limb Exoskeleton Robot
combined group:Wearable Lower-limb Exoskeleton Robot + iTBS

Sponsors

Wuxi Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for cerebrovascular diseases according to the 2019 Edition of the Chinese Classification of Cerebrovascular Diseases, confirmed by cranial CT or MRI; 2.Unilateral hemorrhagic or ischemic cerebral infarction; 3.First onset, with disease duration of 1 to 6 months; 4.Age between 30 and 80 years; 5.No severe cognitive impairment or aphasia; 6.Modified Ashworth Scale (MAS) for spasticity assessment: muscle tone of the affected lower limb = grade 3; 8.Able to walk independently or with assistance for at least 14 meters; 9.Consent from the patient and their family, with signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Unstable condition; 2.Severe cognitive impairment; 3.Accompanied by severe comorbidities involving the musculoskeletal, cardiac, neurological, skin, or vestibular systems; 4.Severe peripheral arterial disease; 5.Resting heart rate 100 bpm, resting blood pressure 200/100 mmHg; 6.Any contraindications to the use of an exoskeleton, such as: polyurethane allergy, leg length discrepancy, height/weight restrictions, open ulcers at device contact points, etc. 7.Any contraindications to the use of transcranial magnetic stimulation (TMS), such as: presence of a cardiac pacemaker or implantable cardioverter-defibrillator, intracranial metal implants, intracranial tumors, history of severe traumatic brain injury, etc.

Design outcomes

Primary

MeasureTime frame
10 Meter Walk Test;

Secondary

MeasureTime frame
FMA-LE;fMRI;EEG;sEMG;Gait;

Countries

China

Contacts

Public ContactChengpan Liang

Wuxi Mental Health Center

lcp101603@163.com+86 510 8301 2698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026